PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
31.20%
Revenue growth above 1.5x RUN's 12.90%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-78.20%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1010.38%
Negative EBIT growth while RUN is at 23.91%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-7584.19%
Negative operating income growth while RUN is at 0.47%. Joel Greenblatt would press for urgent turnaround measures.
-6871.81%
Negative net income growth while RUN stands at 460.66%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-6763.64%
Negative EPS growth while RUN is at 456.14%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-6763.64%
Negative diluted EPS growth while RUN is at 436.85%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.25%
Share count expansion well above RUN's 1.22%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.25%
Diluted share count expanding well above RUN's 1.26%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
39.38%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
41.08%
FCF growth under 50% of RUN's 156.78%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
551.36%
10Y revenue/share CAGR above 1.5x RUN's 231.43%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
610.09%
5Y revenue/share CAGR above 1.5x RUN's 64.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
25.83%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-200.41%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-1610.30%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-387.08%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-320.95%
Negative 10Y net income/share CAGR while RUN is at 1473.60%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1901.08%
Negative 5Y net income/share CAGR while RUN is 1185.12%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-485.94%
Negative 3Y CAGR while RUN is 220.80%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
110.96%
5Y equity/share CAGR above 1.5x RUN's 72.95%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
25.32%
Positive short-term equity growth while RUN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
58.28%
AR growth well above RUN's 8.37%. Michael Burry fears inflated revenue or higher default risk in the near future.
-15.35%
Inventory is declining while RUN stands at 18.52%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.92%
Negative asset growth while RUN invests at 4.18%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-9.42%
We have a declining book value while RUN shows 11.80%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-4.16%
We’re deleveraging while RUN stands at 3.38%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
11.79%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
33.38%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.